Trial Profile
ComparisiOn of Neointimal coVerage betwEen zotaRolimus Eluting Stent and Everolimus Eluting Stent Using Optical Coherence Tomography at 9 Months (COVER OCT).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jun 2012
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary) ; Everolimus
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial infarction
- Focus Pharmacodynamics
- Acronyms COVER-OCT
- 14 May 2009 New trial record